Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999358 | Urologic Oncology: Seminars and Original Investigations | 2016 | 8 Pages |
Abstract
Multimodality treatment approach with upfront chemotherapy followed by surgery can result in a 66% 5-year CSS rate for patients rendered as having pN0 category disease despite initially presenting with node-positive disease. However, as those with residual disease do so poorly, further efforts in refining selection of patients for surgical consolidation are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Philip L. M.D., Daniel L. M.D., Jeevitha B.A., Lianchun M.S., Stephen B. M.D., Jonathan J. M.D., Karen B.A., Sahil B.A., Jay B. M.D., Scott E. M.D., Neema M.D., Arlene M.D., Colin P. M.D., Louis L. M.D., Ashish M. M.D.,